Abstracts 653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Initial Therapy
Watch Session
Dickran Kazandjian, Elizabeth Hill, Candis Morrison, et al.
Jonathan L. Kaufman, Jacob P. Laubach, Douglas Sborov, et al.
550 Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95) clinically relevant abstract
Pieter Sonneveld, Meral Beksac, Bronno Van Der Holt, et al.
Thierry Facon, Christopher P. Venner, Nizar Bahlis, et al.
552 Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda
Raymond L. Comenzo, Efstathios Kastritis, MD, Giovanni Palladini, et al.
Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, et al. and Efstathios Kastritis, MD1